BCIS ACI 2020: This House Believes That, in Most Circumstances, DCB Therapy Is Equivalent to Implantation of DES

Published: 18 March 2020

  • Views:

    Views Icon 74

  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 74

  • Likes:

    Heart Icon 0

Overview

In this video series, chair of the debate, Prof Julian P Gunn (University of Sheffield, Sheffield, UK) introduces the panel and asks the audience of ACI 2020 to cast their votes on the motion “This house believes that, in most circumstances, DCB therapy is equivalent to implantation of DES”. Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK) argues that drug coated balloons (DCB) is equivalent or even better than drug eluting stents (DES) referring on recent data from BASKET-SMALL 2, Debut study. Whilst Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) argues against the motion that DCB therapy is equivalent to implantation of DES. The series concludes by furthering the arguments delivered by Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) and Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK).

This content was provided by the courtesy of BCIS.

Series overview

Part 1

Introduction and Preliminary Poll

Chair of the debate, Prof Julian P Gunn (University of Sheffield, Sheffield, UK) introduces the panel and asks the audience of ACI 2020 to cast their votes on the motion “This house believes that, in most circumstances, DCB therapy is equivalent to implantation of DES”. This recording is provided by the courtesy of BCIS.Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK) argues that drug coated balloons (DCB) is equivalent or even better than drug eluting stents (DES) referring on recent data from BASKET-SMALL 2, Debut study.

1 session

  • Introduction and Preliminary Poll

    Watch now

Part 2

Pro Argument

Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK) argues that drug coated balloons (DCB) is equivalent or even better than drug eluting stents (DES) referring on recent data from BASKET-SMALL 2, Debut study.

1 session

Part 3

Contra Argument

Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) argues against the motion that DCB therapy is equivalent to implantation of DES. He dismisses the pro argument, arguing that the implantation of DES should remain the default approach.

1 session

Part 4

Panel Discussion

The panel and the chairs are concluding the debate by furthering the arguments delivered by Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) and Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK).

1 session

Faculty biographies